Arcturus Therapeutics
ARCT
ARCT
147 hedge funds and large institutions have $453M invested in Arcturus Therapeutics in 2024 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 55 increasing their positions, 47 reducing their positions, and 31 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
26% less capital invested
Capital invested by funds: $609M → $453M (-$157M)
52% less first-time investments, than exits
New positions opened: 15 | Existing positions closed: 31
Holders
147
Holding in Top 10
–
Calls
$2.94M
Puts
$2.98M
Top Buyers
| 1 | +$9.31M | |
| 2 | +$8.14M | |
| 3 | +$5.02M | |
| 4 |
Morgan Stanley
New York
|
+$4.61M |
| 5 |
MB
MPM BioImpact
Boston,
Massachusetts
|
+$4.08M |
Top Sellers
| 1 | -$5.48M | |
| 2 | -$4.23M | |
| 3 | -$3.62M | |
| 4 |
Sumitomo Mitsui Trust Group
Minato-Ku, Tokyo,
Japan
|
-$3.57M |
| 5 |
PCM
Portolan Capital Management
Boston,
Massachusetts
|
-$3M |